Publications by authors named "Andreas Bohle"

Claim this Profile
[
[Evaluation of a prostate cancer aftercare app from the patient perspective: A qualitative study].
Shirin Caroline Pornak, Silke Griemsmann, Andreas Böhle, Achim Lusch, Rainer Schulte

Z Evid Fortbild Qual Gesundhwes· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladder Cancer.
Mathieu Roumiguié, Ashish M Kamat, Trinity J Bivalacqua, Seth P Lerner, Wassim Kassouf

Eur Urol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
Jose Luis Dominguez-Escrig, Benoit Peyronnet, Thomas Seisen, Harman M Bruins, Cathy Yuhong Yuan

Eur Urol Focus· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Marko Babjuk, Andreas Böhle, Maximilian Burger, Otakar Capoun, Daniel Cohen

Eur Urol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, Harman M Bruins, Cathy Yuhong Yuan

Eur Urol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group.
Ashish M Kamat, Richard J Sylvester, Andreas Böhle, Joan Palou, Donald L Lamm

J Clin Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Morgan Rouprêt, Marko Babjuk, Eva Compérat, Richard Zigeuner, Richard J Sylvester

Eur Urol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer.
Ashish M Kamat, J Alfred Witjes, Maurizio Brausi, Mark Soloway, Donald Lamm

J Urol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition.
Donald Lamm, Raj Persad, Maurizio Brausi, Roger Buckley, J Alfred Witjes

J Urol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS).
J Alfred Witjes, Joan Palou, Mark Soloway, Donald Lamm, Ashish M Kamat

BJU Int· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Marko Babjuk, Maximilian Burger, Richard Zigeuner, Shahrokh F Shariat, Bas W G van Rhijn

Eur Urol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European guidelines on upper tract urothelial carcinomas: 2013 update.
Morgan Rouprêt, Marko Babjuk, Eva Compérat, Richard Zigeuner, Richard Sylvester

Eur Urol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group.
Maurizio Brausi, J Alfred Witjes, Donald Lamm, Raj Persad, Joan Palou

J Urol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.
Marko Babjuk, Willem Oosterlinck, Richard Sylvester, Eero Kaasinen, Andreas Böhle

Eur Urol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should all patients receive an immediate chemotherapeutic drug instillation after resection of papillary bladder tumors?
Willem Oosterlinck, Richard Sylvester, Marco Babjuk, Eero Kaasinen, Andreas Böhle

Eur Urol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer.
Paolo Gontero, Andreas Bohle, Per-Uno Malmstrom, Michael A O'Donnell, Marco Oderda

Eur Urol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.
Donald Lamm, Andreas Böhle, Joan Palou, Raj Persad, Maurizio Brausi

Eur Urol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bladder cancer: meta-analysis of BCG versus mitomycin C--a deeper insight?
Andreas Böhle

Nat Rev Urol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study.
Andreas Böhle, Herbert Leyh, Christian Frei, Michael Kühn, Reinhold Tschada

Eur Urol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[EAU guidelines on non-muscle-carcinoma of the bladder].
Marko Babjuk, Willem Oosterlinck, Richard Sylvester, Eero Kaasinen, Andreas Böhle

Actas Urol Esp· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted use of intravesical immunotherapy.
Matthew R Braasch, Andreas Böhle, Michael A O'Donnell

BJU Int· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.
Marko Babjuk, Willem Oosterlinck, Richard Sylvester, Eero Kaasinen, Andreas Böhle

Eur Urol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses.
Henrik Suttmann, Josef Riemensberger, Gabriele Bentien, Dominik Schmaltz, Michael Stöckle

Cancer Res· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycobacteria induce IFN-gamma production in human dendritic cells via triggering of TLR2.
Ingo Fricke, Daniell Mitchell, Jessica Mittelstädt, Nadine Lehan, Holger Heine

J Immunol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of tumor implantation by intravesical gemcitabine in a murine model of superficial bladder cancer.
Carsten Philipp Brocks, Hartwig Büttner, Andreas Böhle

J Urol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis